Horseracing Integrity and Safety Act Summary
Update: Sept. 29, 2020 The United States House of Representatives Sept. 29 passed the Horseracing Integrity and Safety Act of 2020 by a voice vote. The legislation now heads to the Senate, where a timetable for action is not currently known. The
AAEP BOARD VOTES TO SUPPORT FEDERAL BILL, BUT HASN’T CHANGED POSITION ON LASIX
Share By Tom LaMarra Posted: Oct. 19, 2020 The American Association of Equine Practitioners Board of Directors has voted to support the Horseracing Integrity and Safety Act of 2020 based on the need for uniformity and the qualifications of individuals selected to serve
Mid-Atlantic Strategic Plan to Reduce Equine Fatalities Introduces Horsemen’s Brochures
The Mid-Atlantic Plan to Reduce Equine Fatalities has introduced two brochures specifically designed to inform horsemen about the initiative. All seven states in the Mid Atlantic – Delaware, Maryland, New Jersey, New York, Pennsylvania, Virginia and West Virginia – endorsed
MID-ATLANTIC REGION ENDORSES RULE TO RESTRICT IMPROPER USE OF CLENBUTEROL
By: THA http://tharacing.com/mid-atlantic-region-endorses-rule-to-restrict-improper-use-of-clenbuterol/ Posted: Oct. 28, 2020 Continuing a decades-long regional effort to enact uniform medication, safety and welfare reforms, protocols and rules, a coalition of 31 regulatory and stakeholder organizations representing all seven states in the Mid-Atlantic region have unanimously agreed to
Update: Mid-Atlantic Strategic Plan continues to implement important reforms
Read the Article Posted: Nov. 12, 2020 COVID-19 forced Thoroughbred racing into what was for most a two-month hiatus, but the stakeholders in the Mid-Atlantic region turned the down time into an opportunity to focus on its Strategic Plan to Reduce Equine
PENNSYLVANIA THOROUGHBRED TRACKS AWARDED 348 PROGRAMS FOR 2020
Posted: Nov. 18, 2020 Three Thoroughbred tracks have been approved for a total of 348 racing dates for 2021, down from the 434 requested for 2020. The Pennsylvania Horse Racing Commission approved the submissions at its Nov. 17 meeting. With 472 programs
RMTC ISSUES ADVISORY ON USE OF HARPAGOSIDE, DERIVED FROM DEVIL’S CLAW PLANT
http://tharacing.com/rmtc-issues-advisory-on-use-of-harpagoside-derived-from-devils-claw-plant/ Share Posted: Dec. 14, 2020 Harpagoside is a glycoside derived from the Devil’s Claw plant (Harpagophytum procumbens). It is a non-steroidal anti-inflammatory drug that inhibits COX-1 and COX-2, similar to phenylbutazone. There are no FDA-approved harpagoside-containing products. To the extent that Devil’s Claw
PA GOVERNOR AGAIN PROPOSES TO GUT RACE HORSE DEVELOPMENT FUND TRUST
By: Tom LaMarra ShareTweetPin+1Share Posted: Feb. 4, 2021 For the second consecutive year, Gov. Tom Wolf has proposed taking about $200 million—roughly 80% of the 2019 total—from the Pennsylvania Race Horse Development Fund Trust, a move the Pennsylvania Equine Coalition said would result
PA Commission Approves Policy to Ban Race-Day Lasix in 2-year-old Races, Graded Stakes
April 28th, 2021by Tom LaMarra The Pennsylvania Horse Racing Commission April 27 approved an administrative policy that will eliminate the use of race-day Lasix in 2-year-old races and graded stakes effective June 1 of this year. The policy, which was published earlier